Reports of adverse pregnancy outcomes associated with maternal pruritus and liver impairment have circulated since the 1800s, yet the precise diagnosis and management of intrahepatic cholestasis of pregnancy have varied markedly. Recent evidence, including that from individual participant data meta-analyses, has provided an evidence that brings us closer to standardised, and optimal, management of the condition. Based upon increased adverse perinatal outcomes with higher bile acid concentrations, disease management should be according to severity (defined by peak bile acid concentration) in order to recommend appropriate gestation of birth. Similarly, the reduced spontaneous preterm birth rate for patients receiving ursodeoxycholic acid treatment suggests potential benefit for the treatment of patients with moderate-severe disease.
ContributorsNadejda Capatina1,2 and Caroline Ovadia
Disease Category: Pregnancy & childbirth
Disease Name: Intrahepatic Cholestasis of Pregnancy
Age Range: 0 - 100
Sex: Either
Nature of Intervention: N/A
- Systematic review of outcomes measured in trials
- Systematic review